Fulgent Genetics (FLGT) Change in Cash (2015 - 2026)

Fulgent Genetics has disclosed Change in Cash across 12 years of filings, most recently posting -$26.8 million for Q1 2026.

• Change in Cash for Q1 2026 came in at -$26.8 million, down 320.76% year-over-year; the trailing twelve-month figure through Mar 2026 was -$43.9 million (down 444.47% YoY), and the FY2025 annual result was -$5.0 million, up 88.27% from the prior year.
• Change in Cash came in at -$26.8 million for Q1 2026 at Fulgent Genetics, up from -$67.4 million in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $188.2 million in Q1 2022 to a low of -$214.3 million in Q2 2022.
• The 5-year median for Change in Cash is -$2.9 million (2024), against an average of -$8.3 million.
• Peak annual rise in Change in Cash reached 529.2% in 2025, while the deepest fall reached 2227.4% in 2025.
• Fulgent Genetics' Change in Cash stood at -$89.3 million in 2022, then soared by 115.01% to $13.4 million in 2023, then tumbled by 121.63% to -$2.9 million in 2024, then sank by 2227.4% to -$67.4 million in 2025, then jumped by 60.27% to -$26.8 million in 2026.
• The last three Change in Cash figures came in at -$26.8 million (Q1 2026), -$67.4 million (Q4 2025), and $29.8 million (Q3 2025), per Business Quant data.